[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100379506":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":26,"centralContacts":31,"locations":38,"responsibleParty":57,"collaborators":21,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":21,"enrollmentInfo":69,"targetDuration":21,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":21,"overallStatus":41,"whyStopped":21,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Institut du Cancer de Montpellier - Val d'Aurelle","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Tumors and blood collection","EXPERIMENTAL","For all the patients include in the study :\n\n* Blood samples will be collected at different times : before any treatment, at every surgery, one month after any surgery, at progression.\n* Tumours and not tumours tissues will be collected at different times : Before any surgery, one month after any surgery\n\nIn parallel to this biological collection, standardized clinical data will be entered into a database treatment, at every surgery",[13,14],"Biological: biological collection","Other: Tissues collections",[16,22],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"BIOLOGICAL","biological collection","Blood samples collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression",[9],null,{"type":6,"name":23,"description":24,"armGroupLabels":25,"otherNames":21},"Tissues collections","Tumours and not tumours tissues will be collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression",[9],[27],{"name":28,"affiliation":29,"role":30},"François QUENET,MD","Institut régional du cancer de Montpellier","STUDY_CHAIR",[32],{"name":33,"role":34,"phone":35,"phoneExt":36,"email":37},"Aurore MOUSSION","CONTACT","467613100","33","aurore.moussion@icm.unicancer.fr",[39],{"facility":40,"status":41,"city":42,"state":21,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Institut du cancer de Montpellier ICM","RECRUITING","Montpellier","34298","France","FR",{"type":47,"coordinates":48},"Point",[49,50],3.87635,43.61093,{"lat":50,"lon":49},[53],{"name":54,"role":34,"phone":55,"phoneExt":36,"email":56},"QUENET François,MD","0467612354","francois.quenet@icm.unicancer.fr",{"type":58,"investigatorFullName":21,"investigatorTitle":21,"investigatorAffiliation":21,"oldNameTitle":21,"oldOrganization":21},"SPONSOR","100379506","development-of-a-clinical-and-biological-database-in-peritoneal-carcinosis-bcb-carcinose-100379506",false,"NCT04221464","Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)","Development of a Clinical and Biological Database Monocentric and Prospective in Peritoneal Carcinosis","BCB","Inclusion Criteria:\n\n* Patient over the age of 18;\n* Patient managed for peritoneal carcinosis : digestives origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer\n* Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease\n* Patient agree will all study procedure : biological samples \\& tissues samples\n* Patient giving informed consent\n\nExclusion Criteria:\n\n* Patient not affiliated to Social Protection system\n* Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons\n* The level of French is insufficient to consent to the study and to response to the questionnaires\n* Patient under guardianship\n* Pregnancy ou breast-feeding women\n* Patient treated in case of an emergency","ALL","18 Years",{"count":70,"type":71},600,"ESTIMATED","INTERVENTIONAL",[74],"NA","The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.",[77,78],"Cancer","Peritoneal Carcinosis","2025-02-11",{"date":81,"type":82},"2025-02-12","ACTUAL",{"date":84,"type":82},"2019-11-25",{"date":86,"type":71},"2038-02",{"name":5,"class":6},1]